Withings' Sleep Rx Mat Receives FDA 510(k) Clearance for OSA Diagnosis Assistance
核心洞察
The FDA has granted 510(k) clearance to Withings' Sleep Rx Mat (搜索), a device designed to aid in the diagnosis of sleep apnea (搜索) in adults.
The under-mattress mat tracks sleep, breathing, and cardiovascular activity, providing users with a sleep quality score and detailed sleep data.
The device uses pneumatic, sound, and motion sensors to monitor respiratory rate, heart rate, sleep cycles, snoring, and breathing disturbances.
The Sleep Rx Mat (搜索), developed by Withings, has received 510(k) clearance from the FDA for its ability to assist in the diagnosis of obstructive sleep apnea (搜索) (OSA (搜索)) in adults. The device, which fits under any mattress, provides individuals with comprehensive data on their sleep patterns, breathing, and cardiovascular activity throughout the night.
Device Functionality and Features
The Sleep Rx Mat (搜索) utilizes a combination of pneumatic, sound, and motion sensors to monitor various physiological parameters. These include respiratory rate, body movement, continuous heart rate, sleep cycles, and sleep duration. The device also identifies instances of snoring and breathing disturbances, providing a detailed overview of the user's sleep health. After a night of use, individuals receive an easy-to-understand sleep quality score, facilitating a better understanding of their sleep patterns.
Clinical Significance and Impact
Antoine Robillard, Vice President of Withings Health Solutions, emphasized the importance of early and accurate OSA (搜索) diagnosis. "Enabling earlier and more precise diagnosis, Sleep Rx creates a new sleep apnea (搜索) diagnosis and management paradigm," said Robillard. He also noted that traditional one-night assessments are often insufficient for accurate diagnosis. Data from a previous study involving over 11.6 million nights of monitoring with the Withings Sleep Analyzer revealed that a significant proportion of adults had varying degrees of OSA, with misdiagnosis rates ranging from 20% to 50% in single-night studies. Extended monitoring periods reduced these error rates, stabilizing after 14 nights.
Potential Economic Benefits
Undiagnosed sleep apnea (搜索) carries a substantial economic burden, estimated at $150 billion annually. By enabling more efficient and lower-cost home-based OSA (搜索) diagnosis, Sleep Rx has the potential to significantly reduce this burden and improve long-term health outcomes, according to Withings.
Prescription Requirement
The Sleep Rx Mat (搜索) requires a prescription for purchase, ensuring that its use is guided by medical professionals.